Published in Nurs Res Pract on August 10, 2010
Pain and inflammation in women with early-stage breast cancer prior to induction of chemotherapy. Biol Res Nurs (2011) 0.83
Interleukin-6: an emerging regulator of pathological pain. J Neuroinflammation (2016) 0.76
Estrogen-Induced Monocytic Response Correlates with Temporomandibular Disorder Pain: A Case Control Study. J Dent Res (2016) 0.75
Identifying Predictors of Taxane-Induced Peripheral Neuropathy Using Mass Spectrometry-Based Proteomics Technology. PLoS One (2015) 0.75
Principles of interleukin (IL)-6-type cytokine signalling and its regulation. Biochem J (2003) 10.77
Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial. Lancet (2008) 7.37
IL-6: a regulator of the transition from neutrophil to monocyte recruitment during inflammation. Trends Immunol (2003) 3.41
Directing transition from innate to acquired immunity: defining a role for IL-6. J Immunol (2005) 3.17
Inflammatory biomarkers for persistent fatigue in breast cancer survivors. Clin Cancer Res (2006) 2.69
Chemotherapy-induced peripheral neuropathy: prevention and treatment strategies. Eur J Cancer (2008) 2.55
Are the symptoms of cancer and cancer treatment due to a shared biologic mechanism? A cytokine-immunologic model of cancer symptoms. Cancer (2003) 2.48
Glial-cytokine-neuronal interactions underlying the mechanisms of persistent pain. J Neurosci (2007) 2.44
Neurotoxic complications of chemotherapy in patients with cancer: clinical signs and optimal management. Drugs (2003) 2.35
Cytokines, inflammation, and pain. Int Anesthesiol Clin (2007) 2.01
Interleukin-6 trans-signalling in chronic inflammation and cancer. Scand J Immunol (2006) 1.95
Acquiring signalling specificity from the cytokine receptor gp130. Trends Genet (2004) 1.94
Cancer pain and its impact on diagnosis, survival and quality of life. Nat Rev Neurosci (2006) 1.85
Interplay between IFN-gamma and IL-6 signaling governs neutrophil trafficking and apoptosis during acute inflammation. J Clin Invest (2003) 1.69
Intravenous paclitaxel administration in the rat induces a peripheral sensory neuropathy characterized by macrophage infiltration and injury to sensory neurons and their supporting cells. Exp Neurol (2006) 1.67
"Listening" and "talking" to neurons: implications of immune activation for pain control and increasing the efficacy of opioids. Brain Res Rev (2007) 1.62
Peripheral neuropathic pain--a multidimensional burden for patients. Eur J Pain (2001) 1.46
Quality of life in patients with breast cancer before and after diagnosis: an eighteen months follow-up study. BMC Cancer (2008) 1.45
The role of interleukin-6 in nociception and pain. Anesth Analg (2003) 1.44
Pro- and anti-inflammatory cytokine gene expression in rat sciatic nerve chronic constriction injury model of neuropathic pain. Exp Neurol (2001) 1.42
Temporal expression of cytokines and their receptors mRNAs in a neuropathic pain model. Neuroreport (2004) 1.40
Differential expression of cytokines in painful and painless neuropathies. Neurology (2007) 1.38
A key role for gp130 expressed on peripheral sensory nerves in pathological pain. J Neurosci (2009) 1.37
Health and quality of life associated with chronic pain of predominantly neuropathic origin in the community. Clin J Pain (2007) 1.32
Anti-TNF-neutralizing antibodies reduce pain-related behavior in two different mouse models of painful mononeuropathy. Brain Res (2001) 1.32
Pain and quality of life after surgery for breast cancer. Breast Cancer Res Treat (2003) 1.29
Interleukin-6 in combination with its soluble IL-6 receptor sensitises rat skin nociceptors to heat, in vivo. Pain (2002) 1.08
The Paclitaxel acute pain syndrome: sensitization of nociceptors as the putative mechanism. Cancer J (2007) 1.06
Chemotherapy-induced peripheral neuropathy. Oncol Nurs Forum (2005) 1.06
Chemotherapy-induced peripheral neuropathy: a review and implications for oncology nursing practice. Clin J Oncol Nurs (2007) 1.03
Feasibility and validity of the Patient Neurotoxicity Questionnaire during taxane chemotherapy in a phase III randomized trial in patients with breast cancer: N-SAS BC 02. Support Care Cancer (2009) 1.02
Clinical challenges: chemotherapy-induced peripheral neuropathy. Semin Oncol Nurs (2009) 1.02
Up-regulation of interleukin-6 induced by prostaglandin E from invading macrophages following nerve injury: an in vivo and in vitro study. J Neurochem (2005) 1.00
Chemotherapy-induced peripheral neuropathy as a predictor of neuropathic pain in breast cancer patients previously treated with paclitaxel. J Pain (2009) 1.00
Prospective assessment of chemotherapy-induced peripheral neuropathy due to weekly paclitaxel in patients with advanced or metastatic breast cancer (CSP-HOR 02 study). Support Care Cancer (2008) 0.93
Clinical evaluation and patterns of chemotherapy-induced peripheral neuropathy. J Am Acad Nurse Pract (2004) 0.92
The critical role of invading peripheral macrophage-derived interleukin-6 in vincristine-induced mechanical allodynia in mice. Eur J Pharmacol (2008) 0.91
Risk of chemotherapy-induced peripheral neuropathy in large population-based cohorts of elderly patients with breast, ovarian, and lung cancer. Am J Ther (2010) 0.91
Chemotherapy-induced neuropathy. Curr Oncol Rep (2007) 0.91
Chemotherapy-induced peripheral neuropathy. Curr Neurol Neurosci Rep (2008) 0.89
Pain and neuropathy in cancer survivors. Surgery, radiation, and chemotherapy can cause pain; research could improve its detection and treatment. Am J Nurs (2006) 0.87
Up-regulation of matrix metalloproteinase-3 in the dorsal root ganglion of rats with paclitaxel-induced neuropathy. Cancer Sci (2008) 0.86
Predictors of expectancies for post-surgical pain and fatigue in breast cancer surgical patients. Pers Individ Dif (2007) 0.85
Influence of humanized anti-IL-6R antibody, tocilizumab on the activity of soluble gp130, natural inhibitor of IL-6 signaling. Rheumatol Int (2008) 0.77